The development of a new robot pill, called PillBot, could soon replace the invasive medical procedure of endoscopy for many people. Created by American company Endiatx, the device has gone through 50 versions before reaching its current size as a pill and is now entering clinical trials.
To reach this stage, the company obtained $7 million in funding and the creator, Torrey Smith, has tested the prototype up to 43 times. PillBot is currently in phase 3 of clinical trials with the goal of making gastroenterology diagnoses more accessible, convenient, and cost-effective. It is expected to be available for sale in 2026.
The multi-pump propulsion system allows PillBot to move in different directions by emitting harmless fluid jets. It also features a camera that transmits high-resolution video and LED lights, allowing doctors to follow the transmission wirelessly. The device can take advantage of the body’s natural movements to enter the digestive system and is equipped with artificial intelligence to maneuver autonomously.
If successful, PillBot could provide an early and effective detection method for various gastrointestinal conditions. This innovative approach to medical testing may offer a less invasive and more comfortable option for patients in the future.
Amid rising temperatures this week, technology experts are urging caution to protect your devices from…
The Miami Dolphins have undergone significant changes to their roster in recent weeks, releasing players…
Sun Technology (China) Limited (HK:0818) recently announced the disposal of two of its indirect wholly-owned…
Moshi, a new AI-powered chatbot developed by French company Kyutai, is revolutionizing the way users…
The Houston Texans had already built a formidable receiving corps before securing Stefon Diggs in…
The NFL has transformed into a media empire, but its media arm is making some…